 | Up a level |
Wunderink, Richard G., Giamarellos-Bourboulis, Evangelos J., Rahav, Galia, Mathers, Amy J., Bassetti, Matteo 
ORCID: 0000-0002-0145-9740, Vazquez, Jose, Cornely, Oliver A., Solomkin, Joseph, Bhowmick, Tanaya ORCID: 0000-0001-5734-8911, Bishara, Jihad, Daikos, George L., Felton, Tim, Lopez Furst, Maria Jose, Kwak, Eun Jeong, Menichetti, Francesco, Oren, Ilana, Alexander, Elizabeth L., Griffith, David, Lomovskaya, Olga, Loutit, Jeffery, Zhang, Shu, Dudley, Michael N. and Kaye, Keith S.
(2018).
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial.
Infect. Dis. Ther., 7 (4).
S. 439 - 456.
LONDON:
SPRINGER LONDON LTD.
ISSN 2193-6382